# The Safety and Immunogenicity of Haemophilus Influenzae Type b Vaccine in Different Injection Site

> **NCT01761136** · PHASE4 · COMPLETED · sponsor: **Beijing Center for Disease Control and Prevention** · enrollment: 680 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Inoculation in upper arm deltoid
- **BIOLOGICAL:** Inoculation in vastus lateralis muscle

## Key facts

- **NCT ID:** NCT01761136
- **Lead sponsor:** Beijing Center for Disease Control and Prevention
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-12
- **Final completion:** 2013-03
- **Target enrollment:** 680 (ACTUAL)
- **Last updated:** 2013-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761136, "The Safety and Immunogenicity of Haemophilus Influenzae Type b Vaccine in Different Injection Site". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01761136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*